Rigel Pharmaceuticals Inc
Rigel Pharmaceuticals develops small-molecule therapies for hematologic disorders and cancer.
SCHEDULE 13GNov 16Latest SEC filing
Nov 5Latest story
Rigel Pharmaceuticals develops small-molecule therapies for hematologic disorders and cancer.
November 2026
October 2026
August 2026
July 2026